Perrigo Company plc (PIG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Perrigo Company plc (PIG) has a cash flow conversion efficiency ratio of 0.060x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€175.40 Million ≈ $205.06 Million USD) by net assets (€2.94 Billion ≈ $3.43 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Perrigo Company plc to measure how many days the company can operate on defensive assets alone.
Perrigo Company plc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Perrigo Company plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Perrigo Company plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Perrigo Company plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Hui Chuang Da Technology Co.Ltd
SHE:300909
|
0.013x |
|
Wangneng Environment Co Ltd
SHE:002034
|
0.073x |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
0.022x |
|
Telling Telecommunication Holding Co Ltd
SHE:000829
|
-0.232x |
|
Jupiter Wagons Limited
NSE:JWL
|
-0.041x |
|
Ningbo Fujia Industrial Co Ltd
SHG:603219
|
0.020x |
|
WuXi Xinje Electric Co Ltd
SHG:603416
|
0.001x |
|
Home First Finance Company India Limited
NSE:HOMEFIRST
|
-0.121x |
Annual Cash Flow Conversion Efficiency for Perrigo Company plc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Perrigo Company plc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Perrigo Company plc (PIG) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €2.94 Billion ≈ $3.43 Billion |
€238.50 Million ≈ $278.83 Million |
0.081x | -3.30% |
| 2024-12-31 | €4.32 Billion ≈ $5.05 Billion |
€362.90 Million ≈ $424.27 Million |
0.084x | -1.21% |
| 2023-12-31 | €4.77 Billion ≈ $5.57 Billion |
€405.50 Million ≈ $474.07 Million |
0.085x | +34.01% |
| 2022-12-31 | €4.84 Billion ≈ $5.66 Billion |
€307.30 Million ≈ $359.27 Million |
0.063x | +109.18% |
| 2021-12-31 | €5.15 Billion ≈ $6.02 Billion |
€156.30 Million ≈ $182.73 Million |
0.030x | -73.03% |
| 2020-12-31 | €5.66 Billion ≈ $6.61 Billion |
€636.20 Million ≈ $743.78 Million |
0.113x | +68.38% |
| 2019-12-31 | €5.80 Billion ≈ $6.79 Billion |
€387.80 Million ≈ $453.38 Million |
0.067x | -36.14% |
| 2018-12-31 | €5.67 Billion ≈ $6.63 Billion |
€593.00 Million ≈ $693.28 Million |
0.105x | -7.63% |
| 2017-12-31 | €6.17 Billion ≈ $7.21 Billion |
€698.90 Million ≈ $817.09 Million |
0.113x | +3.03% |
| 2016-12-31 | €5.96 Billion ≈ $6.97 Billion |
€654.90 Million ≈ $765.65 Million |
0.110x | -- |
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more